Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Journal of Pharmaceutical Sciences|April 25, 2003
Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effectEun J Kim, Soo K Bae, Hee J Kim, et al.Biopharmaceutics & Drug Disposition|April 15, 2004
Dose-dependent pharmacokinetics of KR-31378, a new neuroprotective agent for ischaemia-reperfusion damage in dogsSun-O Kim, Sang-H Kwak, Byung H Lee, et al.Neurology|September 11, 2015
Is normosmic Parkinson disease a unique clinical phenotype?Dong H Lee, Jungsu S Oh, Jee H Ham, et al.Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|September 19, 2017
Spatial distribution of polycyclic aromatic hydrocarbon and polychlorinated biphenyl sources in the Nakdong River Estuary, South KoreaJun H Lee, Han J Woo, Kap S Jeong, et al.Cancer Research|June 27, 2013
FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancerGeng Zhang, Peijun He, Jochen Gaedcke, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 19, 2017
Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipientsSuzanne M Boyle, Gregory Malat, Meera N Harhay, et al.Journal of Pharmaceutical Sciences|December 18, 2002
Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effectsMi H Lee, Soo K Bae, Eun J Kim, et al.Helicobacter|January 12, 2019
Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistanceJung W Lee, Nayoung Kim, Ryoung H Nam, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 11, 2013
Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter studyChong H Won, Hyung M Lee, Woo S Lee, et al.International Journal of Cancer|November 14, 2007
A stromal gene signature associated with inflammatory breast cancerBrenda J Boersma, Mark Reimers, Ming Yi, et al.Pageof 7